Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors ...
Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership with Alebund Pharmaceuticals to gain exclusive global ...
Finally, New York's Gilgamesh Pharma – a spinout company formed when AbbVie bought Gilgamesh Pharmaceuticals and its ...
NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address cardiometabolic and neuroinflammatory diseases ...
It was founded by Cambridge Innovation Capital and Prof Sir Mark Pepys, Sir Gregory Winter and Prof Daniel Christ ...
The Harvard Undergraduate Venture Capital Group (VCG) will host its fourth annual Entrepreneurship Summit on Saturday, March 28, 2026, from 9:00 AM to 4:30 PM at The Newbury Boston. The Summit is the ...
The fresh funding will help the biotech startup advance a candidate to treat a genetic disorder, “ATTR-CM,” that has become a battleground for companies like Pfizer, Alnylam and BridgeBio.
Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, ...
The Prime Minister pointed to the reduction of energy bills by £117 a year for the average household, a rise in the national ...
Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results